Matts Kågedal

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 13

Top Topics

Early Breast Cancer

Ulcerative Colitis

Top Venues

CPT: pharmacometrics & systems pharmacology

Journal of pharmacokinetics and pharmacodynamics

Cancer chemotherapy and pharmacology

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Kenta Yoshida, Victor Poon, Ajit Dash, Rebecca Kunder, Leslie W Chinn, Matts Kågedal
Simulation-based evaluation of personalized dosing approaches for anti-FGFR/KLB bispecific antibody fazpilodemab. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Kenta Yoshida, Victor Poon, Ajit Dash, Rebecca Kunder, Leslie W Chinn, Matts Kågedal
Simulation-based evaluation of personalized dosing approaches for anti-FGFR/KLB bispecific antibody fazpilodemab. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Kenta Yoshida, Victor Poon, Ajit Dash, Rebecca Kunder, Leslie W Chinn, Matts Kågedal
Simulation-based evaluation of personalized dosing approaches for anti-FGFR/KLB bispecific antibody fazpilodemab. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Kenta Yoshida, Victor Poon, Ajit Dash, Rebecca Kunder, Leslie W Chinn, Matts Kågedal
Simulation-based evaluation of personalized dosing approaches for anti-FGFR/KLB bispecific antibody fazpilodemab. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Kenta Yoshida, Victor Poon, Ajit Dash, Rebecca Kunder, Leslie W Chinn, Matts Kågedal
Simulation-based evaluation of personalized dosing approaches for anti-FGFR/KLB bispecific antibody fazpilodemab. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Kenta Yoshida, Victor Poon, Ajit Dash, Rebecca Kunder, Leslie W Chinn, Matts Kågedal
Simulation-based evaluation of personalized dosing approaches for anti-FGFR/KLB bispecific antibody fazpilodemab. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Kenta Yoshida, Victor Poon, Ajit Dash, Rebecca Kunder, Leslie W Chinn, Matts Kågedal
Simulation-based evaluation of personalized dosing approaches for anti-FGFR/KLB bispecific antibody fazpilodemab. CPT: pharmacometrics & systems pharmacology (2024)
Bei Wang, Rong Deng, Stefanie Hennig, Tanja Badovinac Crnjevic, Monika Kaewphluk, Matts Kågedal, Angelica L Quartino, Sandhya Girish, Chunze Li, Whitney P Kirschbrown
Correction to: Population pharmacokinetic and exploratory exposure-response analysis of the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer in the FeDeriCa study. Cancer chemotherapy and pharmacology (2021)
Sonoko Kawakatsu, Rui Zhu, Wenhui Zhang, Meina T Tang, Tong Lu, Angelica L Quartino, Matts Kågedal
A longitudinal model for the Mayo Clinical Score and its sub-components in patients with ulcerative colitis. Journal of pharmacokinetics and pharmacodynamics (2021)
Bei Wang, Rong Deng, Stefanie Hennig, Tanja Badovinac Crnjevic, Monika Kaewphluk, Matts Kågedal, Angelica L Quartino, Sandhya Girish, Chunze Li, Whitney P Kirschbrown
Population pharmacokinetic and exploratory exposure-response analysis of the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer in the FeDeriCa study. Cancer chemotherapy and pharmacology 88 (3) (2021)
Tong Lu, Yujie Yang, Jin Y Jin, Matts Kågedal
Analysis of Longitudinal-Ordered Categorical Data for Muscle Spasm Adverse Event of Vismodegib: Comparison Between Different Pharmacometric Models. CPT: pharmacometrics & systems pharmacology 9 (2) (2020)
Matts Kågedal, Leonid Gibiansky, Jian Xu, Xin Wang, Divya Samineni, Shang-Chiung Chen, Dan Lu, Priya Agarwal, Bei Wang, Ola Saad, Neelima Koppada, Bernard M Fine, Jin Y Jin, Sandhya Girish, Chunze Li
Platform model describing pharmacokinetic properties of vc-MMAE antibody-drug conjugates. Journal of pharmacokinetics and pharmacodynamics 44 (6) (2017)
Matts Kågedal, Katarina Varnäs, Andrew C Hooker, Mats O Karlsson
Estimation of drug receptor occupancy when non-displaceable binding differs between brain regions – extending the simplified reference tissue model. British journal of clinical pharmacology 80 (1) (2015)